PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Medicine, Akershus University Hospital, Lørenskog, Norway.\', \'Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.\', \'Department of Infectious Diseases, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.\', \'Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.\', \'Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway.\', \'Center for Laboratory Medicine, Østfold Hospital Trust, Grålum, Norway.\', \'Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. helge.rosjo@medisin.uio.no.\', \'Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway. helge.rosjo@medisin.uio.no.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04420-0
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32503662
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32503662>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32503662>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all